Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial. - Wu, Chao; Niu, Xuping; Wang, Xiaohua; Su, Juan; Zhao, Hengguang; Lin, Mao; Yang, Chunjun; Qin, Xiaoming; Guo, Shuping; Jiang, Cunhuo; Tang, Hui; Yang, Haijing; et al. (Dermatology & Therapy, 2026)